Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

infertility

- PMLiVE

WA Health wins Merck account

Communications agency will drive Merck’s UK reach

- PMLiVE

Merck’s new health charity strikes partnership deal with Tanzania

The Merck Foundation will support oncology fellowship programmes for Tanzanian doctors

- PMLiVE

New Merck Foundation appoints Rasha Kelej

She takes up role as CEO of the pharma firm's newly-established non-profit

- PMLiVE

Merck & Co’s anacetrapib rescued by positive phase III trial

Data suggests drug reduces MACE compared to placebo

- PMLiVE

Merck confirms sale of biosimilar division

German pharma group is in 'advanced discussions' with potential buyers

- PMLiVE

Avelumab costs peg back profit at Merck KGaA

Development of its immuno-oncology product is central to Merck's healthcare plans

Marketing strategy in complex environments

Age-old treatment protocols are being replaced with new and innovative treatment paradigms that will revolutionise the healthcare industry for years to come. Kulveer Singh and Mark Assenti talk through what...

Blue Latitude Health

Research Partnership makes annual donation to Forever Projects

Research Partnership has made a seasonal donation of US$5,000 to our chosen charity, Forever Projects

Research Partnership

dengue fever mosquito

Dosing of GSK’s malaria vaccine due to start in 2018

WHO sanctions pilot programme in sub-Saharan Africa to begin gathering field data

- PMLiVE

Merck completes €15m Spanish biotech facility expansion

Enlarged Tres Cantos site will help meet demand for fertility and growth hormone drugs

Merck licences MS brain training programme

Strikes deal with HAPPYneuron to bolster its MSdialog platform for Rebif

- PMLiVE

Merck agrees African digital cooperation deal

Will collaborate with Germany's GIZ on new solutions for the continent

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links